Detailed information for compound 2102908

Basic information

Technical information
  • TDR Targets ID: 2102908
  • Name: (2E,4E,6Z,8E)-8-[3-cyclopropyl-2-(3-methylbut yl)-1-cyclohex-2-enylidene]-3,7-dimethylocta- 2,4,6-trienoic acid
  • MW: 354.526 | Formula: C24H34O2
  • H donors: 1 H acceptors: 2 LogP: 6.82 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(CCC1=C(CCC/C/1=C\C(=C/C=C/C(=C/C(=O)O)/C)\C)C1CC1)C
  • InChi: 1S/C24H34O2/c1-17(2)11-14-23-21(9-6-10-22(23)20-12-13-20)15-18(3)7-5-8-19(4)16-24(25)26/h5,7-8,15-17,20H,6,9-14H2,1-4H3,(H,25,26)/b8-5+,18-7-,19-16+,21-15+
  • InChiKey: SCCVQQDOUFNKGM-RBEOCVBDSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (2E,4E,6Z,8E)-8-(3-cyclopropyl-2-isopentyl-1-cyclohex-2-enylidene)-3,7-dimethyl-octa-2,4,6-trienoic acid
  • (2E,4E,6Z,8E)-8-(3-cyclopropyl-2-isopentyl-1-cyclohex-2-enylidene)-3,7-dimethylocta-2,4,6-trienoic acid
  • (2E,4E,6Z,8E)-8-(3-cyclopropyl-2-isoamyl-1-cyclohex-2-enylidene)-3,7-dimethyl-octa-2,4,6-trienoic acid
  • (2E,4E,6Z,8E)-8-[3-cyclopropyl-2-(3-methylbutyl)-1-cyclohex-2-enylidene]-3,7-dimethyl-octa-2,4,6-trienoic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens retinoid X receptor, alpha Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha Get druggable targets OG5_130073 All targets in OG5_130073
Echinococcus granulosus retinoic acid receptor rxr beta a Get druggable targets OG5_130073 All targets in OG5_130073
Schistosoma mansoni retinoic acid receptor RXR Get druggable targets OG5_130073 All targets in OG5_130073
Schistosoma japonicum ko:K08524 nuclear receptor, subfamily 2, group B, member 1, putative Get druggable targets OG5_130073 All targets in OG5_130073

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi ecdysteroid receptor retinoid X receptor, alpha 435 aa 352 aa 23.9 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Ligand-binding domain of nuclear hormone receptor family protein 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-31 0.0009 0 0.5
Brugia malayi nuclear hormone receptor 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-1 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-41 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-25 0.0009 0 0.5
Loa Loa (eye worm) nuclear hormone receptor family member nhr-1 0.0009 0 0.5
Brugia malayi ecdysteroid receptor 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-19 0.0009 0 0.5
Loa Loa (eye worm) nuclear hormone receptor family member nhr-40 0.0009 0 0.5
Loa Loa (eye worm) steroid hormone receptor 0.0009 0 0.5
Loa Loa (eye worm) nuclear hormone receptor family member nhr-41 0.0009 0 0.5
Loa Loa (eye worm) nuclear hormone receptor family member nhr-49 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor-like 1 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Schistosoma mansoni retinoic acid receptor RXR 0.0128 1 1
Brugia malayi steroid hormone receptor 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-40 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Onchocerca volvulus Protein ultraspiracle homolog 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-14 0.0009 0 0.5
Loa Loa (eye worm) nuclear Hormone Receptor family member 0.0009 0 0.5
Brugia malayi Ligand-binding domain of nuclear hormone receptor family protein 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-49 0.0009 0 0.5
Loa Loa (eye worm) nuclear hormone receptor family member nhr-14 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Echinococcus multilocularis retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha 0.0123 0.9594 1
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog 0.0009 0 0.5
Loa Loa (eye worm) nuclear hormone receptor family member nhr-31 0.0009 0 0.5
Brugia malayi photoreceptor-specific nuclear receptor 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-3 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Onchocerca volvulus Bile acid receptor homolog 0.0009 0 0.5
Brugia malayi nuclear receptor NHR-88 0.0009 0 0.5
Brugia malayi Steroid receptor seven-up type 2 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-19 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5
Onchocerca volvulus 0.0009 0 0.5
Brugia malayi Nuclear hormone receptor family member nhr-25 0.0009 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0009 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) = 20 % Agonist activity at human RXRalpha LBD expressed in HEK293 cells transfected with Gal4 reporter assessed as increase of transcription at 10'-6 M by dual luciferase reporter assay relative to control ChEMBL. 26331194
Activity (binding) > 90 % Binding affinity to human RXRalpha LBD at 1:1 protein and compound ratio by fluorescence quenching method relative to control ChEMBL. 26331194
EC50 (binding) = 19 nM Agonist activity at human RXRalpha LBD expressed in HEK293 cells transfected with Gal4 reporter assessed as increase of transcription by dual luciferase reporter assay ChEMBL. 26331194
Kd (binding) = 35 nM Binding affinity to human RXRalpha LBD by fluorescence quenching method ChEMBL. 26331194

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.